The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Individualized screening trial of innovative glioblastoma therapy (INSIGhT).
 
Brian Michael Alexander
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Precision Health Economics; Schlesinger Associates
 
Lorenzo Trippa
No Relationships to Disclose
 
Sarah C. Gaffey
No Relationships to Disclose
 
Isabel Arrillaga
Consulting or Advisory Role - Insys Therapeutics
 
Eudocia Quant Lee
Consulting or Advisory Role - Genentech
 
Shyam Kumar Tanguturi
Consulting or Advisory Role - Best Doctors, Inc
 
Manmeet Singh Ahluwalia
Honoraria - Elsevier; Itamar Medical (I); Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Incyte; Monteris Medical
Research Funding - Boehringer Ingelheim; Lilly/ImClone; Novartis; Novocure; Spectrum Pharmaceuticals; TRACON Pharma
 
Howard Colman
Consulting or Advisory Role - CytRx Corporation; Genentech; Insys Therapeutics; Novocure; Omniox; Oxigene; Roche; Upsher-Smith
Research Funding - Newlink Genetics; Plexxikon
 
Evanthia Galanis
Consulting or Advisory Role - Genentech/Roche
Research Funding - Genentech/Roche (Inst); Merck (Inst)
 
John Frederick De Groot
Employment - Helsinn Therapeutics (I)
Leadership - ZIOPHARM Oncology (I)
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Celldex; Deciphera; Foundation Medicine; Genentech/Roche; Vascular Biogenics
Speakers' Bureau - Celldex; Deciphera; Omniox; Oxigene
Research Funding - Deciphera; EMD Serono; Lilly; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - AstraZeneca - Research Support; Deciphera Pharmaceuticals - Research Support; Eli Lilly - Research Support; EMD-Serono - Research Support; Novartis - Research Support; Sanofi-Aventis - Research Support
 
Jan Drappatz
Stock and Other Ownership Interests - Bristol-Myers Squibb; Exelixis
Honoraria - UpToDate
Patents, Royalties, Other Intellectual Property - uptodate
 
Andrew B. Lassman
Honoraria - Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; BioClinica; Cortice Biosciences; Genentech/Roche; Novartis; Novocure; Oxigene; Regeneron; SapVax; VBI Vaccines
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Agenus (Inst); Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); e-Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); ImmunoCellular Therapeutics (Inst); Kadmon (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Novocure (Inst); Novocure (Inst); Pfizer (Inst); Plexxikon (Inst); Regeneron (Inst); Stemline Therapeutics (Inst); Tocagen (Inst); VBL Therapeutics (Inst)
 
Louis B. Nabors
No Relationships to Disclose
 
David A. Reardon
Honoraria - Abbvie; Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oxigene; Regeneron; Stemline Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oxigene; Regeneron; Stemline Therapeutics
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Midatech Pharma (Inst); Tragara (Inst)
 
David Schiff
Consulting or Advisory Role - Cavion (Inst); Genentech
 
Mary Roberta Welch
No Relationships to Disclose
 
Keith L. Ligon
Consulting or Advisory Role - Midatech Pharma
Research Funding - Plexxikon
Patents, Royalties, Other Intellectual Property - Molecular Diagnostics Assay Patent
 
Patrick Y. Wen
Research Funding - Celgene; Lilly; Puma Biotechnology